Application of light to treat wounds in the feet of people with Diabetes

Study to test the application of red and blue light in the treatment of wounds in the feet of people with Diabetes

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-7n3y2gq

Enrollment

Unknown

Registered

2025-02-21

Start date

2023-11-25

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot

Interventions

The experimental intervention with phototherapy (n = 23) will consist of the application of visible light in the red (615 to 635 nm) and blue (400 to 415 nm) spectra in three weekly sessions lasting 5

E02.594.540

Eligibility

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years old; of both sexes; already undergoing treatment for type 1 or type 2 diabetes mellitus; with a clinical diagnosis of peripheral neuropathy in the feet; having one or more active ulcers for at least 1 month; and with an ulcer of at least 1 cm² in area

Exclusion criteria

Exclusion criteria: Patients with end-stage chronic kidney disease/hemodialysis, heart failure grades III and IV; or other associated causes of skin ulcers (leprosy, lymphedema/elephantiasis, chronic venous insufficiency, hereditary hemoglobinopathies, squamous cell carcinoma, invasive mycoses, mycobacterioses)

Design outcomes

Primary

Measure	Time frame
It is expected to find a higher percentage of healed area in the intervention group compared to the control group	—

Secondary

Measure	Time frame
No secondary outcomes are expected	—

Countries

Brazil

Contacts

Public ContactPatrícia Moura

Fundação Universidade de Pernambuco.

patricia.moura@upe.br+55-81-999989333

Outcome results

None listed

Source: REBEC (via WHO ICTRP)